All Fellows of the Faculty of Anaesthetists, Royal Australasian College of Surgeons (now Australian and New Zealand College of Anaesthetists) were surveyed by mail regarding their use of prophylactic atropine. They were asked whether their usual practice was to give atropine for the following indications: premedication, induction of anaesthesia, intubation of the trachea, one dose of suxamethonium, a second dose of suxamethonium, halothane anaesthesia, oropharyngeal surgery, bronchoscopy and eye surgery. For each indication they were asked for details regarding their practice concerning neonates, infants, children and adults. The large response rate of 86% of Fellows returning a survey form ensured that the survey was representative of Australian anaesthetic practice. Results indicate a wide variation in practice regarding the prophylactic use of atropine, with neonates, infants and children more likely to receive prophylactic atropine than adults. The majority do not give prophylactic atropine as premedication, but may give it in the younger age groups at induction, and many (67%) only give it if they are to administer suxamethonium to a child. The only indication for which a convincing majority (>80%) of anaesthetists agreed that prophylactic atropine should be given was when a repeated dose of suxamethonium was to be given to neonates, infants or children. A large proportion of anaesthetists (> 80%) agreed that atropine is not necessary prior to halothane anaesthesia in all age groups, nor as premedication, at induction, at intubation, prior to oropharyngeal surgery or prior to eye surgery in adults. These results were compared with the practice at a major paediatric hospital where the practice is not to use routine prophylactic atropine.
The use of anticholinergics in anaesthesia as prophylaxis against bradycardia and for the drying of secretion was once universal, but since the late seventies, and with the disappearance of ether from clinical use in Australia, many anaesthetists state that its use in adults is unwarranted and even inadvisable. I • 2 However, many practitioners feel that anticholinergics (primarily atropine) should still be administered to children routinely prior to anaesthesia. I • 3 -7 Reasons for this include the more active vagal reflexes in children in response to stimuli such as laryngoscopy and intubation, the fear of profound bradycardia after administration of suxamethonium, the oculo-cardiac reflex during strabismus surgery, and for the drying of secretions to reduce the incidence of laryngospasm.
Atropine does have some side-effects.3 It may produce a significant tachycardia, particularly if given intravenously, accompanied by dry mouth, flushed, dry face, and visual blurring. Other arrhythmias have been reported, such as A-V dissociation, A-V block, nodal rhythm and ventricular extrasystole. Sweating is suppressed, and elevation of body temperature may also occur. Atropine may produce central nervous system effects of drowsiness, restlessness, and confusion.
In the Department of Paediatric Anaesthesia of the Women's and Children's Hospital (formerly the Adelaide Children's Hospital) atropine is not used as a premedication, nor is it used routinely at the induction of anaesthesia or before a first dose of suxamethonium. Problems said to occur without atropine have been found to be infrequent and easily treated with intravenous atropine. Pulse rate is a valuable clinical sign in paediatric anaesthesia, and is used to assess depth of anaesthesia, volume status and hypoxia, which can be obscured by the tachycardia caused by atropine.
We report on our survey of Australian anaesthetists to profile the status of atropine use in this country in an attempt to put our practice into perspective, and to ascertain whether further studies are indicated to justify our stance on the issue of prophylactic atropine in paediatric anaesthesia.
MATERIALS AND METHODS
The chosen study population was anaesthetists with Australian Fellowships as listed on the 1990 mailing list of the Faculty of Anaesthetists, Royal Australasian College of Surgeons (now the Australian and New Zealand College of Anaesthetists). The entire population was sampled, using a mailed survey form. A numbered question booklet with an accompanying explanatory letter and reply-paid envelope was sent to each Faculty member. As replies were received, the responses were entered into a computer database against the respondent's number. After five weeks the database was checked for numbers without responses and a reminder letter and second booklet were sent to non-respondents. The database was closed at ten weeks. The wording and design of the letters and question booklet were designed to make it quick and easy to complete, and to encourage a high response rate. 8 The respondents were asked whether their usual practice was to give prophylactic atropine for the following indications: premedication, induction of anaesthesia, intubation of the trachea, one dose of suxamethonium, a second dose of suxamethonium, halothane anaesthesia, oropharyngeal surgery, bronchoscopy, or eye surgery. The indications were chosen after an examination of the available literature according to those recommended by various authors. 5, 7, [9] [10] [11] [12] For each of these indications, the respondent was asked whether they would give prophylactic atropine to the following patient groups: neonates (defined as being less than 44 weeks post-conceptual age), infants (up to one year of age), children, or adults.
The respondents were also asked for their preferred route of administration of atropine, for any additional indications for using an anticholinergic drug, and whether an alternative anticholinergic drug was used.
The following demographic information was also obtained: qualifications, date of obtaining qualifications, place and type of work, and the frequency of anaesthetising neonates, infants, and children.
RESULTS

Response Rate
Of the 1500 Fellows surveyed, 86070 returned a question booklet. Of those, 91070 had provided answers to the questions, whilst the other 9070 had not, because they had retired, or were ill, abroad, or worked in another area, such as intensive care. Thus, 78070 of surveyed Fellows gave responses.
Demographic Information
The information regarding date of qualifying, practice type and workplace, and frequency of anaesthetising children and neonates is displayed in Table 1 . The responses to the first nine questions, dealing with the indications for giving prophylactic atropine to neonates, infants, children and adults, can be seen in Table 2 . The figures are given only for those anaesthetists who indicated they did anaesthetise that particular age group. For example, those respondents who had indicated that they rarely or never anaesthetised neonates were excluded from the count for that particular age group.
Similarly, for the first five indications, namely premedication, induction of anaesthesia, intubation, a first dose of suxamethonium, and a second dose of suxamethonium, respondents were only included in each count if they had not indicated they would give atropine for the previous indication. For example, a respondent who had given atropine as a premedication would be excluded from the count of those who had given it at induction, and any who had given it as a premedication or at induction would be excluded from the count of those giving atropine at intubation. This was because many respondents had commented that they were unsure how to answer this section. If, for example, they had already answered "yes" for the premedication question, did they then answer "yes" for a first dose of suxamethonium also? The cumulative figures for the first five indications can be seen in Table 3 .
The counts for the next four indications (before halothane, oropharyngeal surgery, bronchoscopy, and eye surgery) are shown in the latter section of Table 2 and exclude those anaesthetists who had indicated they would give atropine as a premedication or at induction. Figure 1 shows the preferred routes of administration of prophylactic atropine for various general indications (control secretions, prevention of bradycardia, attentuation of cardiovascular depression).
The respondents indicated that 93 (8070) used prophylactic atropine for other indications, like spinal anaesthesia, or when a combination of vecuronium and fentanyl are used. Other anticholinergics were used by 399 (34070) of anaesthetists.
DISCUSSION
The use of prophylactic anticholinergic drugs in anaesthesia remains highly controversial. Although most authors had agreed in the early seventies that prophylactic anticholinergics for children. Even Banc used a small (0.01 mg/kg) intramuscular dose of atropine as a premedication in his group, while asserting that intravenous atropine was not routinely necessary prior to strabismus surgery in small children. 13 In contrast, Thurlow I4 showed that the use of atropine prior to dental procedures in his group of children was associated with an increased incidence of arrhythmias. The practice at our hospital is to not use routine atropine apart from a few specific indications, e.g. before a second dose of suxamethonium or to treat an actual event such as bradycardia, and then it is administered intravenously. Our experience over some ten years has reinforced our practice, although atropine is always available in a syringe for every anaesthetic. Our surgeons have also not found secretions to be an unacceptable problem over the full range of paediatric procedures.
This survey, sampling the entire population of Fellows of the Faculty of Anaesthetists, Royal Australasian College of Surgeons, produced an exceptionally high response rate of 780;0. The results are, therefore, a reliable representation of the prevailing opinion of Australian anaesthetists, and is representative of Australian practice. Many of the anaesthetists in this representative group anaesthetise children and infants at least once a month (73%) and a smaller proportion anaesthetise neonates once a month (19%). To maintain reliability, only the responses of those who anaesthetise neonates, infants or children once a month or more were included for questions pertaining to those age groups. Since 75% of the respondents qualified as specialists after 1972 (Table 1) , the opinions expressed are likely to represent changes in attitude commensurate with the changes seen in the literature since the seventies.
In 1972, Mirakhur surveyed United Kingdom anaesthetists with respect to routine use of anticholinergic drugs. 12 Over 62% of those anaesthetists used anticholinergic drugs (mainly atropine) routinely as premedication. A further 30-50% of the remainder used them for specific indications such as emergency surgery or paediatrics, and only 5% did not use them at all, even when they administered suxamethonium. In our survey, anaesthetists were specifically asked for their practice with regard to defined age groups. About 15% still use atropine as premedication in adults. This is considerably less than the 62% in Mirakhur's survey, and would conform with a change in practice according to changing opinion as illustrated in the literature and with the use of more modern anaesthetic drugs. Nevertheless, it reveals that there remain a minority of anaesthetists who consider routine anticholinergics necessary in adults. A shortcoming of our survey could be that anaesthetists were asked to indicate use of "atropine" rather than "anticholinergics". Many anaesthetists (34%) indicated that they do use another anticholinergic such as hyoscine and would have increased the percentage using anticholinergic premedication if we had worded the survey differently. However, since hyoscine is presented with papaveretum as a combined-preparation, small-volume injection, which is convenient to use as premedication, this added percentage may not represent anaesthetists who are specifically looking for an anticholinergic effect.
Less than 1 % of the remaining anaesthetists considered "induction" or "intubation" to be indications for prophylactic atropine in adults, and a further 6% would give atropine before a single dose of suxamethonium. Therefore, a total of 22% of anaesthetists would give atropine at some stage before administering a single dose of suxamethonium. Of the remaining anaesthetists, 52% would give atropine before a repeat dose of suxamethonium. Therefore, 62% of anaesthetists give atropine at some stage to adults before repeated suxamethonium. The interesting observations to make from this are that, firstly, a substantial minority of anaesthetists believe that adults require atropine prophylaxis before a single dose of suxamethonium, and, secondly, that there are over 37% of anaesthetists who do not give atropine prophylaxis to adults, even before a repeat dose of suxamethonium. This represents a marked difference from the practice of Mirakhur's survey group, where only 5% would not use an anticholinergic at all.
The practice with regard to neonates, infants and children is quite different. More than twice as many anaesthetists (32%) give atropine premedication to neonates as to adults, and almost as many (26%) to infants, while 20% premedicate children with atropine. Of the remainder, 32% and 24% respectively give atropine to neonates and infants at induction of anaesthesia, but only 9% to children. Fewer consider intubation an indication for prophylactic atropine (8%, 4%, 4%). This means that a total of 5% of anaesthetists will give atropine to neonates at some stage before intubation, 46% to infants, 30% to children, but only 17% to adults. It would seem that there is more inclination to give prophylactic atropine to small children, which conforms to the sway of opinion in the literature, but there is by no means agreement on this point. This pattern continues when a single dose of suxamethonium is administered. Similar percentages of remaining anaesthetists give prophylactic atropine to neonates, infants and children in this instance (24%, 16%, and 21%). This makes a total of 67% of anaesthetists who would give atropine to neonates at some stage before a single dose of A naesthesia and Intensive Care, Vol. 22, No. I, February, 1994 suxamethonium, 54070 to infants, and 42% to children, more than twice the number giving atropine to adults. A repeated dose of suxamethonium is an indication for prophylactic atropine more universally across the age groups, with a further 58% of remaining anaesthetists giving it to neonates, 68% to infants, 61% to children, and 52% to adults. Therefore, by the time a repeat dose of suxamethonium is given, a convincing majority of almost 80% or more of anaesthetists give atropine to neonates, infants and children (86%, 86%, 79%). This is in agreement with Green's recommendation 'O that atropine should precede repeat doses of suxamethonium in children, and indicates a fair degree of agreement among anaesthetists nationally.
The remaining four indications about which anaesthetists were asked were: halothane anaesthesia, oropharyngeal surgery (e.g., tonsillectomy), bronchoscopy, and eye surgery. A vast majority (> 95 %) did not consider halothane anaesthesia as an indication for prophylactic atropine. Fewer than 20% of anaesthetists who had not given atropine as a premedication or at intubation of anaesthesia considered oropharyngeal surgery an indication for prophylactic atropine. This may indicate that anaesthetists consider secretions less of a problem than in previous times. More considered bronchoscopy an indication for prophylactic atropine (23%-31%), with little variation between age groups, but a large number of respondents indicated that they gave atropine in this situation at their surgeon's request. It would seem that secretions are more of a problem now for surgeons than anaesthetists. The previously seen pattern of more anaesthetists considering atropine necessary in neonates, infants and small children was repeated for the indication "eye surgery". A more specific indication, for example, "strabismus surgery", may have yielded a more definitive response. Nevertheless, 31010 and 34% of anaesthetists would give atropine to infants and children if not already given as a premedication or at induction, while only 12% give it to adults. If combined with those giving atropine as a premedication or at induction, approximately 55% would give atropine to infants and children before eye surgery, but fewer than 20% to adults. It appears that more anaesthetists are concerned by the effects of the oculocardiac reflex in children, but much less so in adults. Most anaesthetists gave atropine by the intramuscular route if the aim was reduce secretions (69%) and intravenously to prevent bradycardia (80%) ( Figure  1 ), which is similar to Mirakhur's 1978 survey with 79% for control of secretions and 82% for vagolysis. 12 In summary, more Australian anaesthetists give prophylactic atropine to neonates, infants and children than to adults. The majority do not give the prophylactic atropine as premedication, but may give it in the younger age groups as induction, and many only give it if they are to administer suxamethonium to the child. The only indication for which a convincing majority ( > 80%) of anaesthestists agreed that prophylactic atropine should be given was when a repeated dose of suxamethonium was to be given to neonates, infants or children. A large proportion of anaesthetists ( > 80%) agreed that atropine is not necessary prior to halothane anaesthesia in all age groups, and as premedication, at induction, at intubation, prior to oropharyngeal surgery and prior to eye surgery in adults. The results of this study have not revealed compelling evidence that would suggest that our practice should change.
